First Oral Medication to Treat Moderate-to-Severe Crohn's Disease Completes Successful Phase 3 Trial and Earns FDA Approval.

Press/Media

Period	26 May 2023

Media coverage

Title	First Oral Medication to Treat Moderate-to-Severe Crohn's Disease Completes Successful Phase 3 Trial and Earns FDA Approval.
Media name/outlet	PRWeb Newswire
Country/Territory	United States
Date	26/05/23
URL	ct.moreover.com/?a=50891153061&p=1gw&v=1&x=JqZsJA_x_B4lLO7lu7-IzA
Persons	Jean-Frédéric Colombel